Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 6 (June)

1. Primary mucosal melanoma of head and neck: prognostic value of clear margins.
   Laryngoscope, 116(6): 993-5. [Abstract] [Full-text]
2. MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability.
   J Med Genet, 43(6): 501-6. [Abstract] [Full-text]
3. Transretinal choroidal tumor biopsy with a 25-gauge vitrector.
   Ophthalmology, 113(6): 1028-31. [Abstract] [Full-text]
4. Small choroidal melanocytic lesions: features predictive of growth.
   Ophthalmology, 113(6): 1032-9. [Abstract] [Full-text]
5. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.
   Int J Radiat Oncol Biol Phys, 65(3): 809-16. [Abstract] [Full-text]
6. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study.
   Int J Radiat Oncol Biol Phys, 65(3): 751-9. [Abstract] [Full-text]
7. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
   Int J Radiat Oncol Biol Phys, 65(3): 780-7. [Abstract] [Full-text]
8. Anorectal malignant melanoma: morphologic and immunohistochemical features.
   Am J Clin Pathol, 126(1): 93-100. [Abstract] [Full-text]
9. Tumor iNOS predicts poor survival for stage III melanoma patients.
   Int J Cancer, 119(4): 861-6. [Abstract] [Full-text]
10. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
    Int J Cancer, 119(5): 1194-207. [Abstract] [Full-text]
11. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker.
    Int J Cancer, 119(5): 1014-22. [Abstract] [Full-text]
12. Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells: a relay for chemotherapy?
    Int J Cancer, 119(5): 992-1004. [Abstract] [Full-text]
13. Initial studies on an in vivo action spectrum for melanoma induction.
    Prog Biophys Mol Biol, 92(1): 97-104. [Abstract] [Full-text]
14. Long-term health risk to the skin of ultraviolet radiation.
    Prog Biophys Mol Biol, 92(1): 92-6. [Abstract] [Full-text]
15. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Arch Ophthalmol, 124(6): 838-43. [Abstract] [Full-text]
16. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
    Int J Cancer, 119(2): 317-27. [Abstract] [Full-text]
17. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases.
    Int J Cancer, 119(2): 380-4. [Abstract] [Full-text]
18. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
    Cancer Genet Cytogenet, 168(1): 11-21. [Abstract] [Full-text]
19. Value of sentinel node status as a prognostic factor in melanoma: prospective observational study.
    BMJ, 332(7555): 1423. [Abstract] [Full-text]
20. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    J Clin Oncol, 24(18): 2858-65. [Abstract] [Full-text]
21. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    J Clin Oncol, 24(18): 2849-57. [Abstract] [Full-text]
22. In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna.
    J Am Acad Dermatol, 55(1): 88-97. [Abstract] [Full-text]
23. Diorganotin(IV) and triorganotin(IV) complexes of meso-tetra(4-sulfonatophenyl)porphine induce apoptosis in A375 human melanoma cells.
    Cancer Lett, 238(2): 284-94. [Abstract] [Full-text]
24. APAF-1 signaling in human melanoma.
    Cancer Lett, 238(2): 168-79. [Abstract] [Full-text]
25. Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs.
    BMC Cancer, 6: 141. [Abstract] [Full-text]
26. Anatomic site, sun exposure, and risk of cutaneous melanoma.
    J Clin Oncol, 24(19): 3172-7. [Abstract] [Full-text]
27. Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.
    J Clin Oncol, 24(19): 3164-71. [Abstract] [Full-text]
28. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
    J Clin Oncol, 24(19): 3157-63. [Abstract] [Full-text]
29. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
    Cancer Immunol Immunother, 55(10): 1185-97. [Abstract] [Full-text]
30. The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.
    Cancer Immunol Immunother, 55(10): 1285-93. [Abstract] [Full-text]
31. Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells.
    Cancer Immunol Immunother, 55(10): 1209-18. [Abstract] [Full-text]
32. Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells.
    Cancer Immunol Immunother, 55(10): 1238-46. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.